Clinical trial
Evaluating the Expression Levels of microRNA-10b in Patients With Gliomas
NCT01849952 is registered in ClinicalTrials.gov with Dartmouth-Hitchcock Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Expression Levels of microRNA-10b in Patients With Gliomas
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Phase
- Observational
- Overall status
- Terminated
- Start date
- October 9, 2013
- Completion date
- August 25, 2025
- Enrollment
- 94 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
anaplastic astrocytoma, anaplastic oligoastrocytoma, anaplastic oligodendroglioma, astrocytoma, brain cancer, brain tumors, glioblastoma, oligoastrocytoma, oligodendroglioma